Logo
RadAI Slice
Subscribe

Artificial intelligence-enabled opportunistic identification of immune checkpoint inhibitor-related adverse events using [<sup>18</sup>F]FDG PET/CT.

May 29, 2025pubmed logopapersDOI: 10.1007/s00259-025-07364-2PMID: 40439712

Authors

Spielvogel CP,Lazarevic A,Zisser L,Haberl D,Eseroglou C,Beer L,Hacker M,Calabretta R

Affiliations (3)

  • Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Spitalgasse 23, Vienna, A-1090, Austria.
  • Division of General and Pediatric Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Spitalgasse 23, Vienna, A-1090, Austria. [email protected].

Abstract

View SourceFull Text PDF

Tags

PETDetectionWhole BodyRetrospective ClinicalIn SilicoNoneAcademic Lab

Topics

Journal Article

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.